Ivan Pedrosa, M.D., Ph.D.

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Stock Options
    Ineligible company: 
    Health Tech International
    Topic: 
    Telemedicine
    Date added: 
    12/07/2021
    Relationship end date: 
    12/31/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Merck
    Topic: 
    Advisory board
    Date added: 
    12/07/2021
    Relationship end date: 
    03/04/2021
Return to 156 Renal Cell Carcinoma Multimodality Conference: (030722)